Abstract:The blood‐brain barrier (BBB) poses great difficulties for gene delivery to the brain. To circumvent the BBB, we investigated a novel brain‐targeting gene vector based on the nanoscopic high‐branching den‐drimer, polyamidoamine (PAMAM), in vitro and in vivo. Transferrin (Tf) was selected as a brain‐targeting ligand conjugated to PAMAM via bifunctional polyethylenegly‐col (PEG), yielding PAMAM‐PEG‐Tf. UV and nuclear magnetic resonance (NMR) spectroscopy were used to evaluate the synthesis of vectors. The characteristics and biodistribution of gene vectors were evaluated by fluorescent microscopy, flow cytometry, and a radiolabeling method. The transfection efficiency of vector/DNA complexes in brain capillary endothelial cells (BCECs) was evaluated by fluorescent microscopy and determination of luciferase activity. The potency of vector/DNA complexes was evaluated by using frozen sections and measuring tissue luciferase activity in Balb/c mice after i.v. administration. UV and NMR results demonstrated the successful synthesis of PAMAM‐PEG‐Tf. This vector showed a concentration‐dependent manner in cellular uptake study and a 2.25‐fold brain uptake compared with PAMAM and PAMAM‐PEG in vivo. Transfection efficiency of PAMAM‐PEG‐Tf/DNA complex was much higher than PAMAM/DNA and PAMAM‐PEG/DNA complexes in BCECs. Results of tissue expression experiments indicated the widespread expression of an exogenous gene in mouse brain after i.v. administration. With a PAMAM/DNA weight ratio of 10:1, the brain gene expression of the PAMAM‐PEG‐Tf/DNA complex was ~2‐fold higher than that of the PAMAM/DNA and PAMAM‐PEG/ DNA complexes. These results suggested that PAMAM‐PEG‐Tf can be exploited as a potential nonviral gene vector targeting to brain via noninvasive administration.—Huang, R‐Q., Qu, Y‐H., Ke, W‐L., Zhu, J‐H., Pei, Y‐Y., Jiang, C. Efficient gene delivery targeted to the brain using a transferrin‐conjugated polyethyleneglycol‐modified polyamidoamine dendrimer. FASEB J. 21, 1117–1125 (2007)

Choline-derivate-modified nanoparticles for brain-targeting gene delivery.

Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood–brain barrier

Chitosan-Based Polymeric Nanoparticles as an Efficient Gene Delivery System to Cross Blood Brain Barrier: In Vitro and In Vivo Evaluations

Targeting The Brain With Peg-Plga Nanoparticles Modified With Phage-Displayed Peptides

Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo.

Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice.

Efficient Gene Delivery Targeted to the Brain Using a Transferrin‐conjugated Polyethyleneglycol‐modified Polyamidoamine Dendrimer

Design and formulation of trimethylated chitosan-graft-poly(ε-caprolactone) nanoparticles used for gene delivery.

Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles

Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy (small 45/2022)

Progress on brain-targeting non-viral gene delivery systems

Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.

Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer's disease

Natural Brain Penetration Enhancer-Modified Albumin Nanoparticles for Glioma Targeting Delivery

Penetratin-functionalized PEG–PLA Nanoparticles for Brain Drug Delivery

Gene Delivery into Brain Capillary Endothelial Cells Using Antp-Modified DNA-Loaded Nanoparticles

Choline transporter-targeting and co-delivery system for glioma therapy.

Non-viral gene delivery and therapeutics targeting to brain

Phage-Displayed Peptide-Conjugated Biodegradable Nanoparticles Enhanced Brain Drug Delivery

A Facile Approach to Functionalizing Cell Membrane-Coated Nanoparticles with Neurotoxin-Derived Peptide for Brain-Targeted Drug Delivery.

Alkoxy cyanoacrylate-based nanoparticles with stealth and brain-targeting properties